Eyenovica invests $50 million to establish HYPE reserves, and the company will be renamed "Hyperion DeFi" Eyenovia, a Nasdaq listed company specializing in the development of digital ophthalmic medical technology, announced the completion of a $50 million PIPE financing to purchase the Hyperliquid native token HYPE and plans to become one of its major global verification nodes. The total expected fundraising limit for this transaction is $150 million, and the company will also be renamed "Hyperion DeFi" with the stock code changed to "HYPD". The newly appointed Chief Investment Officer Hyunsu Jung will be responsible for executing the cryptocurrency treasury strategy. Eyenovica will also continue to advance its ophthalmic device FDA registration plan, with the goal of completing it by September 2025.